FUJIFILM Biotechnologies, made up of several legal subsidiaries of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines and advanced therapies. With over 30 years of experience, the company specializes in developing and manufacturing biopharmaceuticals using microbial, mammalian, and host/virus systems.

With more than 5,000 employees, FUJIFILM Biotechnologies operates a fully integrated kojoX™ global network, with major facilities in the United States, the United Kingdom and Denmark. The company’s kojoX operating system harmonizes processes, procedures, systems, data, facility designs and equipment across its global manufacturing network to increase speed while ensuring consistency, quality, scalability and supply chain resilience.

FUJIFILM Biotechnologies offers comprehensive services ranging from proprietary cell line development to process and analytical development, as well as clinical and commercial manufacturing.